the invention relates to the field of immunology , more specifically to adjuvants used to increase the immunogenicity of antigens , for example , for incorporation into vaccines . the invention provides use of a pulmonary surfactant or a component thereof as an adjuvant substance that is able to stimulate an immune response , but , in general , are homologous to substances native to the body .